Alnylam Pharmaceuticals develops and markets RNA interference (RNAi) therapeutics for rare genetic, cardiometabolic, and other diseases.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| George Soros / Soros Fund Mgmt | 33 | New buy | 99,000,000 | $90,690,917 | 1.1% |
| Paul Tudor Jones / Tudor | 61 | Added +100% | 2,400 | $592,176 | 0.0% |
| Ancora | 42 | Holds (flat) | 11 | $2,714 | 0.0% |
| Bridgewater | 55 | Trimmed -71% | 28,463 | $7,022,961 | 0.0% |
| Filed | Insider | Role | Shares | Value | |
|---|---|---|---|---|---|
| 2026-11-12 | SCHULMAN AMY W | director | 1,910 | $299,526 | Form 4 |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-10-08 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-10-08 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-09-22 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-08-22 | Trump, Donald J President | SELL | $15,001 - $50,000 | PTR |
| 2026-07-01 | Trump, Donald J President | SELL | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-05-14 | Trump, Donald J President | SELL | $1,001 -$15,000 | PTR |
| Report | Date | Stance |
|---|---|---|
| #135 — State of the Themes: The End of the Trade (As We Know It) | 2026-11-04 | WATCH |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.